Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology  |  Oncology  |  Family Medicine  |  Urology

Search Medical Condition
Please enter condition
Please choose location

Bladder Cancer Clinical Trials

A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (304) clinical trials

Because of the high risk for development of muscle invasive disease, cystectomy is recommended for CIS, high-grade Ta and T1 patients who experience disease recurrence following intravesical therapy. Vicinium is an experimental agent that may provide an alternative to cystectomy.

Phase

People with bladder cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

People with bladder cancer are asked to participate in a research study being conducted by The Icahn School of Medicine at Mount Sinai and The Mount Sinai Hospital

Phase N/A

People with non-muscle invasive bladder cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

The purpose of this research study is to evaluate the effectiveness and safety of one dose of rAd-IFN with Syn3 (InstiladrinTM) given to patients with High Grade BCG-unresponsive non-muscle invasive bladder cancer. Instiladrin™ is a gene transfer agent and is being developed for transfer of the Interferon a-2b gene in ...

Phase N/A

People with Bladder Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

People with Bladder Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

The purpose of this study is evaluate the efficacy of INCB054828 in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocation who have failed at least 1 previous treatment.

Phase

People with bladder cancer are asked to participate in a research study being conducted by White Plains Hospital

Phase N/A

The purpose of this study is to evaluate the overall response rate (ORR) of INCB054828 as a monotherapy in the treatment of metastatic or surgically unresectable urothelial carcinoma harboring FGF/FGFR alterations.

Phase